Novolog (Pharm-Up 1966) Ltd (NVLG.TA)

ILA 181.1

(0.39%)

Gross Profit Summary of Novolog (Pharm-Up 1966) Ltd

Novolog (Pharm-Up 1966) Ltd's latest annual gross profit in 2023 was 169.16 Million ILS , down -3.96% from previous year.
Novolog (Pharm-Up 1966) Ltd's latest quarterly gross profit in 2024 Q2 was 43.52 Million ILS , down -9.85% from previous quarter.
Novolog (Pharm-Up 1966) Ltd reported a annual gross profit of 176.14 Million ILS in annual gross profit 2022, up 18.25% from previous year.
Novolog (Pharm-Up 1966) Ltd reported a annual gross profit of 148.95 Million ILS in annual gross profit 2021, up 15.21% from previous year.
Novolog (Pharm-Up 1966) Ltd reported a quarterly gross profit of 43.52 Million ILS for 2024 Q2, down -9.85% from previous quarter.
Novolog (Pharm-Up 1966) Ltd reported a quarterly gross profit of 169.16 Million ILS for 2023 FY, down -3.96% from previous quarter.

Annual Gross Profit Chart of Novolog (Pharm-Up 1966) Ltd (2023 - 2013)

Historical Annual Gross Profit of Novolog (Pharm-Up 1966) Ltd (2023 - 2013)

Year	Gross Profit	Gross Profit Growth
2023	169.16 Million ILS	-3.96%
2022	176.14 Million ILS	18.25%
2021	148.95 Million ILS	15.21%
2020	129.28 Million ILS	31.08%
2019	98.63 Million ILS	16.97%
2018	84.32 Million ILS	19.67%
2017	70.46 Million ILS	-2.55%
2016	72.3 Million ILS	9.67%
2015	65.93 Million ILS	2.65%
2014	64.22 Million ILS	26.16%
2013	50.9 Million ILS	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q1	48.28 Million ILS	28.77%
2024 Q2	43.52 Million ILS	-9.85%
2023 FY	169.16 Million ILS	-3.96%
2023 Q1	47.45 Million ILS	7.22%
2023 Q4	37.49 Million ILS	-3.77%
2023 Q2	46.19 Million ILS	-2.66%
2023 Q3	38.96 Million ILS	-15.65%
2022 Q1	44.61 Million ILS	17.34%
2022 FY	176.14 Million ILS	18.25%
2022 Q4	44.26 Million ILS	-0.54%
2022 Q3	44.5 Million ILS	4.04%
2022 Q2	42.77 Million ILS	-4.12%
2021 Q3	36.56 Million ILS	-0.09%
2021 FY	148.95 Million ILS	15.21%
2021 Q2	36.6 Million ILS	-3.1%
2021 Q1	37.77 Million ILS	4.75%
2021 Q4	38.01 Million ILS	3.97%
2020 Q3	32.95 Million ILS	8.89%
2020 Q1	30.71 Million ILS	19.96%
2020 Q2	30.26 Million ILS	-1.45%
2020 FY	129.28 Million ILS	31.08%
2020 Q4	36.05 Million ILS	9.4%
2019 Q2	24.26 Million ILS	-3.15%
2019 FY	98.63 Million ILS	16.97%
2019 Q4	25.6 Million ILS	8.0%
2019 Q3	23.7 Million ILS	-2.32%
2019 Q1	25.05 Million ILS	14.38%
2018 Q1	21.47 Million ILS	10.82%
2018 FY	84.32 Million ILS	19.67%
2018 Q4	21.9 Million ILS	4.88%
2018 Q3	20.88 Million ILS	4.1%
2018 Q2	20.06 Million ILS	-6.56%
2017 Q2	15.86 Million ILS	-14.27%
2017 Q3	16.71 Million ILS	5.3%
2017 FY	70.46 Million ILS	-2.55%
2017 Q4	19.37 Million ILS	15.94%
2017 Q1	18.51 Million ILS	23.24%
2016 Q1	19.06 Million ILS	24.79%
2016 Q4	15.02 Million ILS	-18.15%
2016 FY	72.3 Million ILS	9.67%
2016 Q3	18.35 Million ILS	-7.64%
2016 Q2	19.86 Million ILS	4.2%
2015 FY	65.93 Million ILS	2.65%
2015 Q3	13.14 Million ILS	0.0%
2015 Q4	15.28 Million ILS	16.22%
2014 FY	64.22 Million ILS	26.16%
2013 FY	50.9 Million ILS	0.0%

Peer Gross Profit Comparison of Novolog (Pharm-Up 1966) Ltd

Name	Gross Profit	Gross Profit Difference